Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys-Reference-Cited by-同舟云学术

Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys

Published:2004-09 Issue:25-26 Volume:22 Page:3258-3269
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Maggiorella Maria Teresa,Baroncelli Silvia,Michelini Zuleika,Fanales-Belasio Emanuele,Moretti Sonia,Sernicola Leonardo,Cara Andrea,Negri Donatella R.M,Buttò Stefano,Fiorelli Valeria,Tripiciano Antonella,Scoglio Arianna,Caputo Antonella,Borsetti Alessandra,Ridolfi Barbara,Bona Roberta,Haaft Peter ten,Macchia Iole,Leone Pasqualina,Pavone-Cossut Maria Rosaria,Nappi Filomena,Ciccozzi Massimo,Heeney Jonathan,Titti Fausto,Cafaro Aurelio,Ensoli Barbara

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference69 articles.

1. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III);Arya;Science,1985

2. The trans-activator gene of HTLV-III is essential for virus replication;Fisher;Nature,1986

3. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA;Wu;Science,2001

4. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III;Sodroski;Science,1985

5. Regulatory pathways governing HIV-1 replication;Cullen;Cell,1989

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis;International Journal of Molecular Sciences;2024-01-30

2. Human Immunodeficiency Virus Vaccines;Plotkin's Vaccines;2023

3. New insights into pathogenesis point to HIV-1 Tat as a key vaccine target;Archives of Virology;2021-08-14

4. Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure;Viruses;2020-04-08

5. HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy;Expert Review of Vaccines;2020-01-02